As shown in Figure 1A, fewer SEZ6L2‐positive cells were observed in the normal tissues, whereas SEZ6L2 was highly expressed in the malignant tissues of patients with CRC. This evidence concerns the gene SEZ6L2 and colorectal carcinoma.